UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2026
Commission File Number No. 001-42155
Ping An Biomedical Co., Ltd.
(Registrant’s Name)
22/F, China United Plaza
1002-1008, Tai Nan West Street
Cheung Sha Wan
Kowloon, Hong Kong
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
In connection with an annual general meeting of shareholders (the “Meeting” or “Annual General Meeting”) of Ping An Biomedical Co., Ltd. (the “Company”), an exempted company incorporated under the laws of the Cayman Islands, the Company hereby furnishes the following documents:
Exhibits
| Exhibit No. | Description of Exhibit | |
| 99.1 | Notice and Proxy Statement of Annual General Meeting of Shareholders | |
| 99.2 | Form of Proxy Card | |
| 99.3 | Form of the Second Amended and Restated Memorandum of Association |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| PING AN BIOMEDICAL CO., LTD. | ||
| Date: March 9, 2026 | By: | /s/ Pijun Liu |
| Name: | Pijun Liu | |
| Title: | Chairman of the Board of Directors | |
2